Multicenter prospective, randomized amblyopia screening and treatment trials have created a new body of evidence upon which to base clinical practices of screening, diagnosis, and treatment. This collection of content, based on IRIS Registry measure IRIS50: Amblyopia: Interocular Visual Acuity, reviews the best evidence-based approach for diagnosing and treating amblyopia while advocating for early, appropriate screening.